SUSQUEHANNA INTERNATIONAL GROUP, LLP - ADAPTIVE BIOTECHNOLOGIES COR ownership

ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 212 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q2 2022. The put-call ratio across all filers is 0.37 and the average weighting 0.2%.

Quarter-by-quarter ownership
SUSQUEHANNA INTERNATIONAL GROUP, LLP ownership history of ADAPTIVE BIOTECHNOLOGIES COR
ValueSharesWeighting
Q3 2023$671,506
-58.8%
123,212
-49.3%
0.00%
Q2 2023$1,629,416
+33.4%
242,834
+75.6%
0.00%
Q1 2023$1,221,348
-74.3%
138,318
-77.8%
0.00%
-100.0%
Q4 2022$4,756,313
+612.0%
622,554
+563.6%
0.00%
Q3 2022$668,000
-27.5%
93,809
-17.7%
0.00%
Q2 2022$922,000
-46.3%
113,985
-7.9%
0.00%
Q1 2022$1,718,000
-46.3%
123,788
+8.6%
0.00%
Q4 2021$3,198,000
+17.1%
114,000
+41.8%
0.00%
Q3 2021$2,732,000
-60.0%
80,381
-51.9%
0.00%
-100.0%
Q2 2021$6,823,000
+15.5%
166,984
+13.8%
0.00%
Q1 2021$5,906,000
-75.7%
146,689
-64.3%
0.00%
-100.0%
Q4 2020$24,308,000
+117.7%
411,104
+79.1%
0.00%
-33.3%
Q3 2020$11,166,000
+5.8%
229,600
+5.2%
0.00%0.0%
Q2 2020$10,556,000
+38.3%
218,173
-20.6%
0.00%
+50.0%
Q1 2020$7,632,000
+11.7%
274,726
+20.3%
0.00%0.0%
Q4 2019$6,832,000
+15.9%
228,321
+19.7%
0.00%0.0%
Q3 2019$5,893,000190,7000.00%
Other shareholders
ADAPTIVE BIOTECHNOLOGIES COR shareholders Q2 2022
NameSharesValueWeighting ↓
Eagle Health Investments LP 1,014,860$14,086,0003.47%
Triatomic Management LP 297,048$4,123,0003.35%
Diametric Capital, LP 265,000$3,678,0002.03%
Matrix Capital Management Company, LP 11,572,590$160,628,0001.93%
VIKING GLOBAL INVESTORS LP 29,993,708$416,313,0001.68%
TIGER MANAGEMENT L.L.C. 589,311$8,180,0001.35%
Aristotle Atlantic Partners, LLC 759,412$10,541,0000.65%
Casdin Capital, LLC 1,000,000$13,880,0000.62%
Pier Capital, LLC 339,541$4,713,0000.60%
Leeward Financial Partners, LLC 68,504$951,0000.59%
View complete list of ADAPTIVE BIOTECHNOLOGIES COR shareholders